| PRD_001175 | Name: | P-((((benzyloxy)carbonyl)amino)methyl)-N-((S)-1-(isobutylamino)-4-methyl-1-oxopentan-2-yl)phosphonamidic acid | Formula: | C19 H32 N3 O5 P | Definition date: | 2014-04-02 | Last modified: | 2017-09-14 |
|
| PRD_001177 | Name: | P-((((benzyloxy)carbonyl)amino)methyl)-N-((S)-4-methyl-1-oxo-1-(phenethylamino)pentan-2-yl)phosphonamidic acid | Formula: | C23 H32 N3 O5 P | Definition date: | 2014-04-02 | Last modified: | 2017-09-14 |
|
| PRD_001178 | Name: | P-((((benzyloxy)carbonyl)amino)methyl)-N-((S)-4-methyl-1-oxo-1-(propylamino)pentan-2-yl)phosphonamidic acid | Formula: | C18 H30 N3 O5 P | Definition date: | 2014-04-02 | Last modified: | 2017-09-14 |
|
| PRD_001179 | Name: | P-((((benzyloxy)carbonyl)amino)methyl)-N-((S)-4-methyl-1-(((S)-2-methylbutyl)amino)-1-oxopentan- 2-yl)phosphonamidic
acid | Formula: | C20 H34 N3 O5 P | Definition date: | 2014-04-02 | Last modified: | 2017-09-14 |
|
| PRD_001180 | Name: | P-((((benzyloxy)carbonyl)amino)methyl)-N-((S)-1-((3,3-dimethylbutyl)amino)-4-methyl-1-oxopentan-2-yl)phosphonamidic
acid | Formula: | C21 H36 N3 O5 P | Definition date: | 2014-04-02 | Last modified: | 2017-09-14 |
|
| PRD_001182 | Name: | P-((((benzyloxy)carbonyl)amino)methyl)-N-((S)-4-methyl-1-(neopentylamino)-1-oxopentan-2-yl)phosphonamidic acid | Formula: | C20 H34 N3 O5 P | Definition date: | 2014-04-02 | Last modified: | 2017-09-14 |
|
| PRD_001183 | Name: | P-((((benzyloxy)carbonyl)amino)methyl)-N-((S)-1-(isopentylamino)-4-methyl-1-oxopentan-2-yl)phosphonamidic acid | Formula: | C20 H34 N3 O5 P | Definition date: | 2014-04-02 | Last modified: | 2017-09-14 |
|
| PRD_001200 | Name: | N-[(benzyloxy)carbonyl]-L-leucyl-N-{(1R,2S)-1-hydroxy-4-methyl-1-[(2R)-2-methyloxiran-2-yl]pentan-2-yl}-L-leucinamide | Formula: | C29 H47 N3 O6 | Definition date: | 2014-02-12 | Last modified: | 2017-09-14 |
|
| PRD_001205 | Name: | N-[(benzyloxy)carbonyl]-L-leucyl-N-[(2S,3S)-2-hydroxy-5-methyl-1-oxo-1-(phenylamino)hexan-3-yl]-L-leucinamide | Formula: | C33 H48 N4 O6 | Definition date: | 2014-02-12 | Last modified: | 2017-09-14 |
|
| PRD_001206 | Name: | N-[(benzyloxy)carbonyl]-L-leucyl-N-[(3S)-5-methyl-1-(methylsulfonyl)hexan-3-yl]-L-leucinamide | Formula: | C28 H47 N3 O6 S | Definition date: | 2014-02-12 | Last modified: | 2017-09-14 |
|
| PRD_001207 | Name: | N-[(benzyloxy)carbonyl]-L-leucyl-N-[(2R,3S)-1,2-dihydroxy-5-methylhexan-3-yl]-L-leucinamide | Formula: | C27 H45 N3 O6 | Definition date: | 2014-02-12 | Last modified: | 2017-09-14 |
|
| PRD_001210 | Name: | N-[(benzyloxy)carbonyl]-L-leucyl-N-[(2S)-1-hydroxy-4-methylpentan-2-yl]-L-leucinamide | Formula: | C26 H43 N3 O5 | Definition date: | 2014-02-12 | Last modified: | 2017-09-14 |
|
| PRD_001217 | Name: | N-[(2S,3S)-7-amino-1-chloro-2-hydroxyheptan-3-yl]-4-methylbenzenesulfonamide (Bound Form) | Formula: | C14 H23 Cl N2 O3 S | Definition date: | 2014-04-23 | Last modified: | 2017-09-14 |
|
| PRD_001230 | Name: | D-valyl-N-[(2S,3S)-7-amino-1-chloro-2-hydroxyheptan-3-yl]-L-leucinamide | Formula: | C18 H37 Cl N4 O3 | Definition date: | 2014-09-03 | Last modified: | 2017-09-14 |
|
| PRD_001231 | Name: | L-phenylalanyl-N-[(2S,3S)-6-carbamimidamido-1-chloro-2-hydroxyhexan-3-yl]-L-phenylalaninamide | Formula: | C25 H35 Cl N6 O3 | Definition date: | 2014-09-03 | Last modified: | 2017-09-14 |
|
| PRD_001244 | Name: | N-[(benzyloxy)carbonyl]-L-leucyl-N-{(2S,3S)-1-[(2,4-dimethylphenyl)amino]-2-hydroxy-5-methyl-1-oxohexan-3-yl}-L-leucinamide | Formula: | C35 H52 N4 O6 | Definition date: | 2014-08-13 | Last modified: | 2017-09-14 |
|
| PRD_001258 | Name: | N-[4-({[(6S)-2-amino-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)benzoyl]-L-gamma-glutamyl-L-gamma-glutamyl-L-glutamic acid | Formula: | C29 H37 N9 O12 | Definition date: | 2015-01-14 | Last modified: | 2017-09-14 |
|
| PRD_002274 | Name: | N-[(6aR,12R,15aR,17R,21R,23aR)-17,21-dimethyl-6,11,15,20,23-pentaoxooctadecahydro-2H,6H,11H,15H-pyrido[2,1-i]dipyrrolo[2,1-c:2',1'-l][1,4,7,10,13]oxatetraazacyclohexadecin-12-yl]-Nalpha-[(2E)-pent-2-enoyl]-L-phenylalaninamide | Formula: | C37 H50 N6 O8 | Definition date: | 2017-06-21 | Last modified: | 2017-06-21 |
|
| PRD_002261 | Formula: | C92 H138 N27 O24 S | Description: | single helix from the B-domain of protein A bound to IgG1 Fc | Definition date: | 2017-05-24 | Last modified: | 2017-05-24 |
|
| PRD_000902 | Name: | N-hexanoyl-L-valyl-N~1~-[(3S,4S)-3-hydroxy-2,6-dimethylhept-1-en-4-yl]-N~5~,N~5~-dimethyl-L-glutamamide | Formula: | C27 H50 N4 O5 | Description: | vinylketone carmaphycin analogue VNK1, single bound form | Definition date: | 2014-01-29 | Last modified: | 2017-05-04 |
|
| PRD_000904 | Name: | N-hexanoyl-L-valyl-N~1~-[(3S,4S)-3-hydroxy-2,6-dimethylheptan-4-yl]-N~5~,N~5~-dimethyl-L-glutamamide | Formula: | C27 H52 N4 O5 | Description: | vinylketone carmaphycin analogue VNK1, double bound form | Definition date: | 2014-01-29 | Last modified: | 2017-05-04 |
|
| PRD_001077 | Name: | Cul1WHB-Dcn1P-stapled acetylated | Formula: | C71 H133 N17 O16 Se | Definition date: | 2012-12-12 | Last modified: | 2017-05-04 |
|
| PRD_001131 | Name: | GRAMICIDIN A | Formula: | C90 H133 N19 O17 | Description: | GRAMICIDIN A IS A HEXADECAMERIC HELICAL PEPTIDE WITH ALTERNATING D,L CHARACTERISTICS.
THE N-TERM IS FORMYLATED (RESIDUE 0). THE C-TERM IS CAPPED WITH ETHANOLAMINE (RESIDUE 16). | Definition date: | 2013-07-02 | Last modified: | 2017-05-04 |
|
| PRD_001132 | Name: | CYCLOSPORIN D | Formula: | C63 H113 N11 O12 | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI. CYCLOSPORIN D IS A NATURAL ANALOG OF CYCLOSPORIN A
OBTAINED FROM A DIFFERENT NUTRIENT BROTH AND
DIFFERS FROM CYCLOSPORIN IN RESIDUE 6 (ABA6VAL) | Definition date: | 2013-07-02 | Last modified: | 2017-05-04 |
|
| PRD_001238 | Name: | PEPSTATIN ANALOGUE ISOVALERYL-VAL-VAL-STA-O-ET | Formula: | C25 H47 N3 O6 | Definition date: | 2014-06-04 | Last modified: | 2017-05-04 |
|